Suspension of trading
Comparison Chart Avidity Biosciences, Inc.
Stocks
RNA
US05370A1088
Pharmaceuticals
|
Market Closed -
Nasdaq
16:00:00 2026-02-26 EST
|
5-day change | 1st Jan Change | ||
| 72.82 USD | +0.03% |
|
-.--% | +0.96% |
| 08-20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 08-13 | Atrium Therapeutics Earns Another $15 Million Milestone Payment From Bristol Myers Squibb | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Biopharmaceuticals | +0.03% | -.--% | +0.96% | +51.55% | +216.20% | 11.3B |
-
|
-
|
-
|
- Stock Market
- Stocks
- RNA Stock
- Charts Avidity Biosciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
